Literature DB >> 18600420

In vivo imaging of microglial activation using a peripheral benzodiazepine receptor ligand: [11C]PK-11195 and animal PET following ethanol injury in rat striatum.

Hiroshi Toyama1, Kentaro Hatano, Hiromi Suzuki, Masanori Ichise, Sotaro Momosaki, Gen Kudo, Fumitaka Ito, Takashi Kato, Hiroshi Yamaguchi, Kazuhiro Katada, Makoto Sawada, Kengo Ito.   

Abstract

OBJECTIVE: To investigate whether [(11)C]PK-11195, a specific peripheral benzodiazepine receptors (PBRs) ligand for positron emission tomography (PET), can show activated microglia in a rat brain injury model.
METHODS: On day 1, ethanol was injected into the rat's right striatum (ST) using a stereotaxic operative procedure. On day 3, head magnetic resonance imaging (MRI) scans for surgically treated rats were performed to evaluate ethanol injury morphologically. On day 4, dynamic PET scans (17 injured rats and 7 non-injured controls) were performed for 60 min with an animal PET scanner under chloral hydrate anesthesia following a bolus injection of [(11)C]PK-11195 through tail vein. Because PBRs are present throughout the brain, there is no suitable receptor-free reference region. The reference tissue model may not be applicable because of low target to background ratio for low affinity of [(11)C]PK-11195 to PBRs. We evaluated the PBRs binding with regions of interest (ROIs)-based approach to estimate total distribution volume (V). We used an integral from 0 min to 60 min (V (60)) as an estimate of V. On the coronal PET image, ROIs were placed on bilateral ST. Differences in right/left ST V (60) ratios between lesioned and unlesioned control rats were compared using unpaired t tests. Immunohistochemical staining was performed for confirming the presence of activated microglia following decapitation on the PET experiment day.
RESULTS: The right/left ST V (60) ratios in lesioned rats (1.07 +/- 0.08) were significantly higher than those in unlesioned control rats (1.00 +/- 0.06, P < 0.05). On immunohistochemical staining, activated microglia were exclusively observed in the injured right ST but not in the noninjured left ST of the injury rats and the bilateral ST of the non-injured control rats.
CONCLUSIONS: These results suggest that [(11)C]PK-11195 PET imaging would be a useful tool for evaluating microglial activation in a rat brain injury model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600420     DOI: 10.1007/s12149-008-0136-1

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  10 in total

Review 1.  Imaging microglial activation during neuroinflammation and Alzheimer's disease.

Authors:  Sriram Venneti; Clayton A Wiley; Julia Kofler
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-04       Impact factor: 4.147

Review 2.  Targeted delivery with peptidomimetic conjugated self-assembled nanoparticles.

Authors:  Esmaiel Jabbari
Journal:  Pharm Res       Date:  2008-12-17       Impact factor: 4.200

3.  Alcohol Increases Exosome Release from Microglia to Promote Complement C1q-Induced Cellular Death of Proopiomelanocortin Neurons in the Hypothalamus in a Rat Model of Fetal Alcohol Spectrum Disorders.

Authors:  Sayani Mukherjee; Miguel A Cabrera; Nadka I Boyadjieva; Gregory Berger; Bénédicte Rousseau; Dipak K Sarkar
Journal:  J Neurosci       Date:  2020-09-04       Impact factor: 6.167

4.  [(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive therapy efficacy in rat experimental autoimmune encephalomyelitis model.

Authors:  Lin Xie; Tomoteru Yamasaki; Naotsugu Ichimaru; Joji Yui; Kazunori Kawamura; Katsushi Kumata; Akiko Hatori; Norio Nonomura; Ming-Rong Zhang; Xiao-Kang Li; Shiro Takahara
Journal:  J Neuroimmune Pharmacol       Date:  2011-10-29       Impact factor: 4.147

5.  Role of microglia in ethanol's apoptotic action on hypothalamic neuronal cells in primary cultures.

Authors:  Nadka I Boyadjieva; Dipak K Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

6.  Neurological Symptoms and Their Associations With Inflammatory Biomarkers in the Chronic Phase Following Traumatic Brain Injuries.

Authors:  Gangqin Li; Hao Liu; Yong He; Zeqing Hu; Yan Gu; Yan Li; Yi Ye; Junmei Hu
Journal:  Front Psychiatry       Date:  2022-06-24       Impact factor: 5.435

7.  Increased cerebral (R)-[(11)C]PK11195 uptake and glutamate release in a rat model of traumatic brain injury: a longitudinal pilot study.

Authors:  Hedy Folkersma; Jessica C Foster Dingley; Bart N M van Berckel; Annemieke Rozemuller; Ronald Boellaard; Marc C Huisman; Adriaan A Lammertsma; W Peter Vandertop; Carla F M Molthoff
Journal:  J Neuroinflammation       Date:  2011-06-14       Impact factor: 8.322

8.  Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [(11)C]CB184 and [ (11)C]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [ (11)C](R)-PK11195.

Authors:  Kentaro Hatano; Katsuhiko Sekimata; Takashi Yamada; Junichiro Abe; Kengo Ito; Mikako Ogawa; Yasuhiro Magata; Jun Toyohara; Kiichi Ishiwata; Giovanni Biggio; Mariangela Serra; Valentino Laquintana; Nunzio Denora; Andrea Latrofa; Giuseppe Trapani; Gaetano Liso; Hiromi Suzuki; Makoto Sawada; Masahiko Nomura; Hiroshi Toyama
Journal:  Ann Nucl Med       Date:  2015-01-24       Impact factor: 2.668

9.  In Vivo MRI of Functionalized Iron Oxide Nanoparticles for Brain Inflammation.

Authors:  Tang Tang; Anthony Valenzuela; Fanny Petit; Sarah Chow; Kevin Leung; Fredric Gorin; Angelique Y Louie; Marc Dhenain
Journal:  Contrast Media Mol Imaging       Date:  2018-06-25       Impact factor: 3.161

10.  In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation.

Authors:  Yuji Tanimoto; Tomoteru Yamasaki; Narihito Nagoshi; Yuichiro Nishiyama; Satoshi Nori; Soraya Nishimura; Tsuyoshi Iida; Masahiro Ozaki; Osahiko Tsuji; Bin Ji; Ichio Aoki; Masahiro Jinzaki; Morio Matsumoto; Yasuhisa Fujibayashi; Ming-Rong Zhang; Masaya Nakamura; Hideyuki Okano
Journal:  Stem Cells Transl Med       Date:  2020-01-06       Impact factor: 6.940

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.